Erratum to “Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1063-1075] - Kiyotaka Uchiyama; Daisuke Kamano; Tomoki Nagasaka; Eriko Yoshida Hama; Ryoichi Shirai; Rena Sumura; Ei Kusahana; Akane Yanai; Takashin Nakayama; Takahide Kimura; Rina Takahashi; Takahiro Kasai; et al. (Kidney International Reports)